IL-SHIPPEO
23.4.2024 10:40:26 CEST | Business Wire | Press release
Shippeo, a leading provider of multimodal shipment visibility, announced today their Spring 2024 Platform release, introducing over 70 new features and enhancements, including a new parcel tracking solution rebuilt from the ground up, as well as improvements to road, ocean container, and carbon emissions tracking, along with significant user experience improvements.
“I’m thrilled to announce that our latest Spring platform release is available to customers from today,” says Chief Product Officer, Anand Medepalli. “Our entirely rebuilt parcel tracking solution that we’re releasing today is market-leading. Reengineered from the ground up, Parcel Visibility offers enhanced scalability to support our continued expansion into North America and APAC, where we are seeing significant appetite for a simpler, more convenient tool that delivers the high data quality and reliability that shippers and freight forwarders demand in this rapidly changing and competitive market. In addition, we’re taking the carbon footprint measurement capabilities for users even further with new Carbon Visibility features, while bringing a number of new features and enhancements to our Road and Ocean Visibility solutions.”
All-new parcel tracking solution to boost customer experience
A newly imagined, simple and convenient parcel tracking solution helps shippers and freight forwarders boost customer experience while accelerating invoicing. With more granular visibility into parcel shipment milestones, recipients have greater oversight of where their shipments are, when they will arrive, while offering shippers easier identification of incomplete delivery root causes. Key features include:
- 360 degree event tracking coverage available after booking, for all major parcel carriers and all in one platform
- Tracking links and customer portals provide recipients with detailed parcel journey information, in client’s own branding
- Aggregated delivery timestamps for users, enabling easy sharing, faster invoicing and optimized cash flow
- On-time In-full performance insights to help users assess carrier performance
Advanced, accurate carbon emissions reporting capabilities enabling targeted reductions
Organizations are increasingly required to measure scope 3 carbon emissions, to comply with rapidly evolving regulations, as a result of stakeholder or customer pressure, or simply to measure progress towards reaching carbon neutrality goals. As a result, carbon emissions reporting continues to rise up the priority list for supply chain management, and shippers in general. Shippeo’s latest Spring Release brings new capabilities to the platform’s GLEC framework-accredited Carbon Visibility solution, making calculations more accurate across all transport modes, and offering powerful insights needed to enable targeted emissions reductions.
- Ocean Carrier Intermodal calculations: Ocean container transport carbon calculations now take into account pre and/or post carriage legs when booked end to end with an ocean carrier, simplifying data collection for a more comprehensive picture of environmental impact, while identifying the most carbon-intensive, and potentially most expensive, legs for door-to-door shipments
- Insetting support: Shippers can now override the default fuel type for truck loads and ocean containers, and select from biofuel and electricity fuel types, to account for lower emissions levels achieved through insetting agreements with road or ocean carriers
- Data completeness dashboards: After launching the same feature for Ocean Visibility users last November, Road Visibility users can now also access a scorecard detailing how complete road shipment data is, identifying missing data, such as weight, truck size, fuel type, and more, to help users take steps to improve calculation accuracy
Further features for Road and Ocean Visibility enhancing user experience, predictive ETA performance, and data quality
The platform update will also introduce new features and enhancements to the Road and Ocean Visibility solutions, including:
- All-new Homepage: An entirely new and fully customizable homepage is coming for all users (including carriers), making it possible to drag and drop widgets and configure their own control center, KPIs and visualize all of their most important action items in one place. Metrics for shipments in various stages can be viewed at a glance, for easier identification and management of deliveries at risk
- Long-distance shipment ETA: Shippeo’s accuracy SLA-backed predictive ETA has been enhanced for full truckload shipments where journey times are two or more days, with accuracy increasing by as much as 70%
- Container Journey identification: Enhanced logic improves identification of container journey boundaries, offering greater data quality when operational processes are more complex and data received from ocean carriers via EDI 315 messages is incomplete
New Developer Portal for more autonomous API integrations and monitoring:
A new portal offers developers a suite of tools for faster, more autonomous API integrations and interface monitoring, for both Shipper and Carrier IT teams, including:
- Full autonomy to interface: Access clear API documentation sorted by transport mode and use-case, examples and screenshots to illustrate steps, explanations of technical language used, and detailed swaggers enabling developers to interface with little to no additional support
- Authentication method selection: Users can choose between JWT or Oauth2 authentication methods
- Integration health monitoring: Self-service analytics, alerts and monitoring allow customers to autonomously check logs and dashboards to monitor the health of their API interfaces and debug errors
About Shippeo
Shippeo is a global leader in real-time multimodal transportation visibility, helping major shippers and logistics service providers operate more resilient, sustainable, and customer-centric supply chains. This is made possible with highly accurate real-time operational visibility and Transport Process Automation™ to streamline transportation processes, reduce latency and improve operational efficiency. Their Multimodal Visibility Network integrates with more than 1,000 TMS, telematics and ELD systems, enabling Shippeo’s platform to provide instant access to real-time shipment tracking across all transport modes, in a single portal, through an intuitive user experience. A proprietary and industry-leading machine learning algorithm offers unmatched ETA accuracy, allowing supply chain companies to quickly anticipate problems, proactively alert customers, efficiently manage exceptions with collaborative workflows, and GHG emissions from supply chain transport. Hundreds of customers, including global brands like Ahold Delhaize, AkzoNobel, Amazon, Avery Dennison, Arlanxeo, Barilla, Birra Peroni, Bosch Siemens Hausgeräte, Carrefour, Coca-Cola HBC, DP World, Evonik, Fujifilm, Jaguar Land Rover, Hartmann Group, Heineken, Kuehne+Nagel, L’Oréal, LVMH, Renault Group, Sabic, Saint-Gobain, XPO Logistics and Yamaha Motor, trust Shippeo to track more than 50 million shipments per year across 130 countries. Learn more at www.shippeo.com, LinkedIn, Facebook, X (formerly Twitter)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240423236212/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
